![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 3, 1872-1877, January 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Different mutations in the
BRI2 gene cause rare neurodegenerative
conditions, termed familial British dementia (FBD) and familial Danish
dementia (FDD). The mutant genes encode BRI-L and BRI-D, the
precursors of fibrillogenic ABri and ADan peptides, respectively. We
previously reported that furin processes both BRI-L and its wild type
counterpart, BRI, resulting in the secretion of C-terminal peptides;
elevated levels of peptides were generated from BRI-L. In the
present study, we show that inducible expression of
Proteolytic Processing of Familial British
Dementia-associated BRI Variants
EVIDENCE FOR ENHANCED INTRACELLULAR ACCUMULATION OF
AMYLOIDOGENIC PEPTIDES*
,
,
, and
¶
Department of Neurobiology, Pharmacology and
Physiology, The University of Chicago, Chicago, Illinois 60637 and the
§ Laboratory for Molecular Oncology, Center for Human
Genetics, University of Leuven and Flanders Interuniversity Institute
for Biotechnology, 3000 Leuven, Belgium
1-antitrypsin Portland, a furin inhibitor, inhibits the endoproteolysis of BRI and
BRI-L in a dose-dependent manner. Moreover, comparison of the activities of several proprotein convertases reveals that furin is
most efficient in endoproteolysis of BRI and BRI-L; PACE4, PC6A, PC6B,
and LPC show much lower activities. Interestingly, LPC also exhibits
enhanced cleavage of BRI-L compared with BRI. Finally, we demonstrate
that BRI-D is also processed by furin and, like BRI-L, the cleavage
of BRI-D is more efficient than that of BRI. Interestingly, while the
ABri peptide is detected both intracellularly and in the medium, the
ADan peptide accumulates predominantly in intracellular
compartments. We propose that intracellular accumulation of
amyloidogenic ADan or ABri peptides results in the neuronal damage
leading to FDD and FBD, respectively.
*
This study was supported by the National Institutes of
Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
L. Martin, R. Fluhrer, K. Reiss, E. Kremmer, P. Saftig, and C. Haass Regulated Intramembrane Proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b J. Biol. Chem., January 18, 2008; 283(3): 1644 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS Curbing activation: proprotein convertases in homeostasis and pathology FASEB J, July 1, 2003; 17(10): 1215 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kelly and W. E. Balch Amyloid as a natural product J. Cell Biol., May 12, 2003; 161(3): 461 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |